Company Filing History:
2 out of 3 
2 out of 817 Years Active: 2015-2018
Title: Glenn Guerin – Innovator in Neuropharmaceuticals
Introduction
Glenn Guerin, an accomplished inventor based in Shreveport, LA, is recognized for his significant contributions to the field of neuropharmaceuticals. With two patents to his name, Guerin's innovations focus on advanced compositions and methods aimed at treating addiction, psychiatric disorders, and neurodegenerative diseases.
Latest Patents
Guerin's latest patents highlight his dedication to addressing critical health challenges. His inventions include pharmaceutically acceptable compositions that feature metyrapol as the sole active ingredient, as well as formulations that combine metyrapol with additional agents. Notably, his work emphasizes clarity in targeting the hypothalamic-pituitary-adrenal (HPA) axis while minimizing cortisol production inhibition in the adrenal gland. One innovative approach includes formulations designed to preferentially affect the skin or utilize dosages that do not significantly lower plasma cortisol levels.
Career Highlights
Throughout his career, Glenn Guerin has been affiliated with prominent organizations such as Embera Neurotherapeutics, Inc. and Louisiana State University and Agricultural & Mechanical College. His work at these institutions has paved the way for advancements in the treatment of complex neurological conditions, showcasing his commitment to the intersection of research and practical application.
Collaborations
Guerin has collaborated with esteemed professionals, including Nicholas E. Goeders and Barbara S. Fox. Their joint efforts have contributed to the exploration and development of innovative therapeutic approaches, demonstrating the collaborative spirit necessary for breakthroughs in the medical field.
Conclusion
As an inventor and researcher, Glenn Guerin stands out for his innovative work in neuropharmaceuticals. His patents not only reflect his creativity and expertise but also offer hope for effective treatments for difficult-to-manage conditions. Through his collaborations and career endeavors, Guerin continues to influence the landscape of pharmaceutical innovation.